{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:26Z","timestamp":1786982666940,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s13555-025-01430-1","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T23:04:43Z","timestamp":1746227083000},"page":"1599-1606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Impact of Step Therapy on Individuals with Psoriatic Disease in the USA: Patient and Provider Perspectives"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8342-4954","authenticated-orcid":false,"given":"Georgia","family":"Marquez-Grap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2077-8213","authenticated-orcid":false,"given":"Dayna L.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Leeolou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Kranyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"issue":"10","key":"1430_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJMp2117582","volume":"386","author":"RE Sachs","year":"2022","unstructured":"Sachs RE, Kyle MA. Step therapy\u2019s balancing act\u2014protecting patients while addressing high drug prices. N Engl J Med. 2022;386(10):901\u20134. https:\/\/doi.org\/10.1056\/NEJMp2117582.","journal-title":"N Engl J Med"},{"issue":"3","key":"1430_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1017\/S1744133121000153","volume":"17","author":"L Tharp","year":"2022","unstructured":"Tharp L, Rothblatt Z. Do patients benefit from legislation regulating step therapy? HEPL. 2022;17(3):282\u201397. https:\/\/doi.org\/10.1017\/S1744133121000153.","journal-title":"HEPL"},{"key":"1430_CR3","unstructured":"Snow J, Feldman M, Kappel J. The impact of step-therapy policies on patients. Xcenda. 2019. https:\/\/www.xcenda.com\/-\/media\/assets\/xcenda\/english\/content-assets\/white-papers-issue-briefs-studies-pdf\/impact-of-step-therapy-on-patients_final_1019.pdf. Accessed 23 Jan 2025."},{"issue":"3","key":"1430_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40744-019-0159-1","volume":"6","author":"J Belasco","year":"2019","unstructured":"Belasco J, Wei N. Psoriatic arthritis: what is happening at the joint? Rheumatol Ther. 2019;6(3):305\u201315. https:\/\/doi.org\/10.1007\/s40744-019-0159-1.","journal-title":"Rheumatol Ther"},{"issue":"19","key":"1430_CR5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945. https:\/\/doi.org\/10.1001\/jama.2020.4006.","journal-title":"JAMA"},{"key":"1430_CR6","unstructured":"Adib D, Pereira I. UnitedHealthcare CEO shooting opens up \u201cvolcanic\u201d anger toward health insurance agencies. ABC News. https:\/\/abc7chicago.com\/post\/unitedhealthcare-ceo-shooting-opens-volcanic-anger-health-insurance-agencies\/15630641\/#:~:text=Crowe%20said%20more%20than%20250,annually%20by%20health%20insurance%20companies. Accessed 9 Dec 2024."},{"issue":"2","key":"1430_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.18553\/jmcp.2021.27.2.268","volume":"27","author":"T Karmarkar","year":"2021","unstructured":"Karmarkar T, Dubois RW, Graff JS. Stakeholders find that step therapy should be evidence-based, flexible, and transparent: assessing appropriateness using a consensus approach. J Manage Care Spec Pharm. 2021;27(2):268\u201375. https:\/\/doi.org\/10.18553\/jmcp.2021.27.2.268.","journal-title":"J Manage Care Spec Pharm"},{"issue":"3","key":"1430_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jaad.2017.05.019","volume":"77","author":"S Singh","year":"2017","unstructured":"Singh S, Taylor C, Kornmehl H, Armstrong AW. Psoriasis and suicidality: A systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(3):425-440.e2. https:\/\/doi.org\/10.1016\/j.jaad.2017.05.019.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1430_CR9","doi-asserted-by":"publisher","first-page":"22927","DOI":"10.1038\/s41598-023-48723-z","volume":"13","author":"E Toledano","year":"2023","unstructured":"Toledano E, Hidalgo C, G\u00f3mez-Lech\u00f3n L, et al. SLEEP quality in patients with psoriatic arthritis and its relationship with disease activity and comorbidities: a cross-sectional study. Sci Rep. 2023;13(1):22927. https:\/\/doi.org\/10.1038\/s41598-023-48723-z.","journal-title":"Sci Rep"},{"issue":"8","key":"1430_CR10","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s13555-024-01211-2","volume":"14","author":"P Smith","year":"2024","unstructured":"Smith P, Jin JQ, Spencer RK, et al. Psoriasis and sleep disturbance: a US population-based study using the NHANES database. Dermatol Ther (Heidelb). 2024;14(8):2277\u201383. https:\/\/doi.org\/10.1007\/s13555-024-01211-2.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1430_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2023.111543","volume":"176","author":"M Guo","year":"2024","unstructured":"Guo M, Su J, Zheng S, Chen B. Sleep in psoriasis: a meta-analysis. J Psychosom Res. 2024;176: 111543. https:\/\/doi.org\/10.1016\/j.jpsychores.2023.111543.","journal-title":"J Psychosom Res"},{"key":"1430_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.674460","volume":"12","author":"J Nowowiejska","year":"2021","unstructured":"Nowowiejska J, Baran A, Flisiak I. Mutual relationship between sleep disorders, quality of life and psychosocial aspects in patients with psoriasis. Front Psychiatry. 2021;12:674460. https:\/\/doi.org\/10.3389\/fpsyt.2021.674460.","journal-title":"Front Psychiatry"},{"issue":"12","key":"1430_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052935","volume":"7","author":"AW Armstrong","year":"2012","unstructured":"Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the national psoriasis foundation survey data 2003\u20132011. PLoS ONE. 2012;7(12):e52935. https:\/\/doi.org\/10.1371\/journal.pone.0052935.","journal-title":"PLoS ONE."},{"issue":"3","key":"1430_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","volume":"15","author":"JU Scher","year":"2019","unstructured":"Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15(3):153\u201366. https:\/\/doi.org\/10.1038\/s41584-019-0175-0.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1430_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00296-023-05519-8","volume":"44","author":"CA Hibbs","year":"2024","unstructured":"Hibbs CA. Predicting comorbid mental health difficulties in people with autoimmune arthritis. Rheumatol Int. 2024;44(3):459\u201368. https:\/\/doi.org\/10.1007\/s00296-023-05519-8.","journal-title":"Rheumatol Int"},{"issue":"Suppl 1","key":"1430_CR16","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/msc.1690","volume":"20","author":"DR Jadon","year":"2022","unstructured":"Jadon DR, Helliwell PS. The role of the multidisciplinary team in the management of psoriatic arthritis. Musculoskeletal Care. 2022;20(Suppl 1):S32\u201340. https:\/\/doi.org\/10.1002\/msc.1690.","journal-title":"Musculoskeletal Care"},{"key":"1430_CR17","unstructured":"American Medical Association. 2017 AMA Prior Authorization Physician Survey. 2017. https:\/\/www.ama-assn.org\/sites\/ama-assn.org\/files\/corp\/media-browser\/public\/arc\/prior-auth-2017.pdf. Accessed 24 Jan 2025."},{"issue":"6","key":"1430_CR18","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/ajt.14703","volume":"18","author":"LM Potter","year":"2018","unstructured":"Potter LM, Maldonado AQ, Lentine KL, et al. Transplant recipients are vulnerable to coverage denial under medicare part D. Am J Transplant. 2018;18(6):1502\u20139. https:\/\/doi.org\/10.1111\/ajt.14703.","journal-title":"Am J Transplant"},{"issue":"11","key":"1430_CR19","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1377\/hlthaff.2021.00822","volume":"40","author":"KL Lenahan","year":"2021","unstructured":"Lenahan KL, Nichols DE, Gertler RM, Chambers JD. Variation In use and content of prescription drug step therapy protocols, within and across health plans. Health Aff (Millwood). 2021;40(11):1749\u201357. https:\/\/doi.org\/10.1377\/hlthaff.2021.00822.","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"1430_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029\u201372. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.057.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1430_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/art.40726","volume":"71","author":"JA Singh","year":"2019","unstructured":"Singh JA, Guyatt G, Ogdie A, et al. 2018 American College of Rheumatology\/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheumatol. 2019;71(1):5\u201332. https:\/\/doi.org\/10.1002\/art.40726.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1430_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s41669-019-0152-1","volume":"4","author":"N Boytsov","year":"2020","unstructured":"Boytsov N, Zhang X, Evans KA, Johnson BH. Impact of plan-level access restrictions on effectiveness of biologics among patients with rheumatoid or psoriatic arthritis. Pharmacoecon Open. 2020;4(1):105\u201317. https:\/\/doi.org\/10.1007\/s41669-019-0152-1.","journal-title":"Pharmacoecon Open"},{"issue":"1","key":"1430_CR23","doi-asserted-by":"publisher","first-page":"2328185","DOI":"10.1080\/09546634.2024.2328185","volume":"35","author":"B Florenzo","year":"2024","unstructured":"Florenzo B, Lyons CE, Smith AD, Remington C, Flowers RH, Bryer B. Mandated step therapy for dupilumab delays the inevitable. J Dermatol Treat. 2024;35(1):2328185. https:\/\/doi.org\/10.1080\/09546634.2024.2328185.","journal-title":"J Dermatol Treat"},{"issue":"9","key":"1430_CR24","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.18553\/jmcp.2021.27.9.1309","volume":"27","author":"LZ Rand","year":"2021","unstructured":"Rand LZ, Kesselheim AS. International reference pricing for prescription drugs: a landscape analysis. J Manage Care Spec Pharm. 2021;27(9):1309\u201313. https:\/\/doi.org\/10.18553\/jmcp.2021.27.9.1309.","journal-title":"J Manage Care Spec Pharm"},{"key":"1430_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o693","volume":"376","author":"K Jenei","year":"2022","unstructured":"Jenei K, Prasad V, Lythgoe MP. High US drug prices have global implications. BMJ. 2022;376: o693. https:\/\/doi.org\/10.1136\/bmj.o693.","journal-title":"BMJ"},{"issue":"5","key":"1430_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/papr.12073","volume":"14","author":"BT Suehs","year":"2014","unstructured":"Suehs BT, Louder A, Udall M, Cappelleri JC, Joshi AV, Patel NC. Impact of a pregabalin step therapy policy among medicare advantage beneficiaries. Pain Pract. 2014;14(5):419\u201326. https:\/\/doi.org\/10.1111\/papr.12073.","journal-title":"Pain Pract"},{"issue":"8","key":"1430_CR27","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.clinthera.2008.08.009","volume":"30","author":"JF Farley","year":"2008","unstructured":"Farley JF, Cline RR, Schommer JC, Hadsall RS, Nyman JA. Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications. Clin Ther. 2008;30(8):1524\u201339. https:\/\/doi.org\/10.1016\/j.clinthera.2008.08.009. (Discussion 1506\u20131507).","journal-title":"Clin Ther."},{"issue":"2","key":"1430_CR28","first-page":"123","volume":"15","author":"TL Mark","year":"2009","unstructured":"Mark TL, Gibson TB, McGuigan KA. The effects of antihypertensive step-therapy protocols on pharmaceutical and medical utilization and expenditures. Am J Manage Care. 2009;15(2):123\u201331.","journal-title":"Am J Manage Care"},{"issue":"6","key":"1430_CR29","first-page":"e208","volume":"22","author":"K Rajagopalan","year":"2016","unstructured":"Rajagopalan K, Hassan M, Boswell K, Sarnes E, Meyer K, Grossman F. Review of outcomes associated with restricted access to atypical antipsychotics. Am J Manage Care. 2016;22(6):e208-214.","journal-title":"Am J Manage Care"},{"key":"1430_CR30","unstructured":"Sullivan M, Scott M, OLaughlin C, Hopkins C, Nell A. Step therapy can lead to higher OOP costs for Crohn\u2019s disease patients. Avalere Health. 2020. https:\/\/avalere.com\/insights\/step-therapy-can-lead-to-higher-oop-costs-for-crohns-disease-patients. Accessed 24 Jan 2025."},{"issue":"12","key":"1430_CR31","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.18553\/jmcp.2018.24.12.1230","volume":"24","author":"DL Shaw","year":"2018","unstructured":"Shaw DL, Dhruva SS, Ross JS. Coverage of novel therapeutic agents by medicare prescription drug plans following FDA approval. J Manage Care Spec Pharm. 2018;24(12):1230\u20138. https:\/\/doi.org\/10.18553\/jmcp.2018.24.12.1230.","journal-title":"J Manage Care Spec Pharm"},{"key":"1430_CR32","unstructured":"Step Therapy. Step therapy legislation by state. Overview. 2024. https:\/\/steptherapy.com\/step-therapy-legislation-by-state\/. Accessed 24 Jan 2025."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01430-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01430-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01430-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T06:00:03Z","timestamp":1748671203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01430-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01430-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Wilson Liao has received research grant funding from Amgen, Janssen, Leo, and Novartis. Wilson Liao is an Editorial Board member of\n                      Dermatology and Therapy\n                      . Wilson Liao was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Georgia Marquez-Grap, Dayna Pham, Andrea Leung, Melissa C. Leeolou, and Allison Kranyak have no disclosures to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}